Jeff Rudy

Jeff Rudy has 28 years of clinical research and development experience across multiple therapeutic areas at a number of large and small pharmaceutical companies. For the past 14 years, he has worked on advanced therapies (cell and gene therapy) for cardiovascular indications at a number of startup biotech companies (XyloCor Therapeutics, Capricor and Celladon), serving on the senior executive teams as Vice President of Clinical Operations and Research & Development Operations. Prior to Celladon, he was Senior Director at Pfizer and held positions at Gilead Sciences, Cell Genesys and Amgen. Mr. Rudy received a B.S. in Microbiology from The Ohio State University.